Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Beyond innovation: why rare disease gene therapy needs a reset
AuthorsMaram E. Abdalla Elsayed; Robert E. MacLaren
Affiliations1. University of Oxford; 2. Oxford University Hospitals NHS Foundation Trust
Sequencing and switching among IL-17 and IL-23 biologics in plaque psoriasis: real-world lessons and precision strategies for the future
AuthorsClarissa Fava; Edoardo Zompanti; Eleonora De Luca; Clara De Simone; Ketty Peris; Giacomo Caldarola
Affiliations1. Fondazione Policlinico Universitario A. Gemelli - IRCCS; 2. Università Cattolica del Sacro Cuore
Advances in antibody-drug conjugate-based combination therapy strategies for non-small cell lung cancer
AuthorsYunqi Mi; Shan Wang; Yuhao Wang; Shiqi Ding; Jinxiang Wu; Jing Yu
Affiliations1. Capital Medical University
Targeting autoimmune pulmonary alveolar proteinosis with GM-CSF: insights from clinical trials and emerging therapies
AuthorsMargaret Higgins; Niamh Boyle; Cormac McCarthy
Affiliations1. St. Vincent’s University Hospital; 2. University College Dublin
Targeting ineffective erythropoiesis in thalassemia: biologic therapies and emerging therapeutic strategies
AuthorsAli T. Taher; Mohammad Hassan Hodroj; Maria Domenica Cappellini
Affiliations1. American University of Beirut Medical Center; 2. McGill University Health Center; 3. Unit of Medicine and Metabolic Disease, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
